Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Claude Camelin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cardiovascular Research|November 14, 2003
Biomolecular interactions between human recombinant beta-MyHC and cMyBP-Cs implicated in familial hypertrophic cardiomyopathyJeanne Flavigny, Philippe Robert, Jean-Claude Camelin, et al.
Chemmedchem|March 17, 2007
Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligandsMichael Amon, Xavier Ligneau, Jean-Claude Camelin, et al.
Bioorganic & Medicinal Chemistry|March 31, 2009
Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligandsDorota Łazewska, Kamil Kuder, Xavier Ligneau, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 9, 2008
A solid phase parallel synthesis of diverse amides as dopamine D3 receptor ligandsMickaël Jean, Jacques Renault, Jean-Claude Camelin, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Acidic elements in histamine H(3) receptor antagonistsKerstin Sander, Yvonne von Coburg, Jean-Claude Camelin, et al.
The Journal of Biological Chemistry|August 1, 2002
Neuropeptide AF and FF modulation of adipocyte metabolism. Primary insights from functional genomics and effects on beta-adrenergic responsivenessIsabelle Lefrere, Pierre De Coppet, Jean-Claude Camelin, et al.
Organic Letters|May 8, 2010
First metal-containing histamine H3 receptor ligandsKerstin Sander, Tim Kottke, Claas Hoffend, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cardiovascular Research|November 14, 2003
Biomolecular interactions between human recombinant beta-MyHC and cMyBP-Cs implicated in familial hypertrophic cardiomyopathyJeanne Flavigny, Philippe Robert, Jean-Claude Camelin, et al.
Chemmedchem|March 17, 2007
Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligandsMichael Amon, Xavier Ligneau, Jean-Claude Camelin, et al.
Bioorganic & Medicinal Chemistry|March 31, 2009
Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligandsDorota Łazewska, Kamil Kuder, Xavier Ligneau, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 9, 2008
A solid phase parallel synthesis of diverse amides as dopamine D3 receptor ligandsMickaël Jean, Jacques Renault, Jean-Claude Camelin, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Acidic elements in histamine H(3) receptor antagonistsKerstin Sander, Yvonne von Coburg, Jean-Claude Camelin, et al.
The Journal of Biological Chemistry|August 1, 2002
Neuropeptide AF and FF modulation of adipocyte metabolism. Primary insights from functional genomics and effects on beta-adrenergic responsivenessIsabelle Lefrere, Pierre De Coppet, Jean-Claude Camelin, et al.
Organic Letters|May 8, 2010
First metal-containing histamine H3 receptor ligandsKerstin Sander, Tim Kottke, Claas Hoffend, et al.
Pageof 1